Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer.
Saved in:
| Title: | Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer. |
|---|---|
| Authors: | Cursano G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Concardi A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Frascarelli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Mane E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Mangione E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Santaguida S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Tosoni D; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Pece S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. Konstantinos.venetis@ieo.it., Rocco EG; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Fusco N; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. |
| Source: | Molecular diagnosis & therapy [Mol Diagn Ther] 2025 Nov; Vol. 29 (6), pp. 849-857. Date of Electronic Publication: 2025 Sep 06. |
| Publication Type: | Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40914741 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cursano+G%22">Cursano G</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Concardi+A%22">Concardi A</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ivanova+M%22">Ivanova M</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Frascarelli+C%22">Frascarelli C</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mane+E%22">Mane E</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mangione+E%22">Mangione E</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Santaguida+S%22">Santaguida S</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Tosoni+D%22">Tosoni D</searchLink>; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pece+S%22">Pece S</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Marra+A%22">Marra A</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Criscitiello+C%22">Criscitiello C</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Viale+G%22">Viale G</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Venetis+K%22">Venetis K</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. Konstantinos.venetis@ieo.it.<br /><searchLink fieldCode="AU" term="%22Rocco+EG%22">Rocco EG</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fusco+N%22">Fusco N</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101264260%22">Molecular diagnosis & therapy</searchLink> [Mol Diagn Ther] 2025 Nov; Vol. 29 (6), pp. 849-857. <i>Date of Electronic Publication: </i>2025 Sep 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101264260 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2000 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211771062%22">11771062 </searchLink><i>NLM ISO Abbreviation: </i>Mol Diagn Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40914741 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40291-025-00814-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 849 Titles: – TitleFull: Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cursano G – PersonEntity: Name: NameFull: Concardi A – PersonEntity: Name: NameFull: Ivanova M – PersonEntity: Name: NameFull: Frascarelli C – PersonEntity: Name: NameFull: Mane E – PersonEntity: Name: NameFull: Mangione E – PersonEntity: Name: NameFull: Santaguida S – PersonEntity: Name: NameFull: Tosoni D – PersonEntity: Name: NameFull: Pece S – PersonEntity: Name: NameFull: Marra A – PersonEntity: Name: NameFull: Criscitiello C – PersonEntity: Name: NameFull: Curigliano G – PersonEntity: Name: NameFull: Viale G – PersonEntity: Name: NameFull: Venetis K – PersonEntity: Name: NameFull: Rocco EG – PersonEntity: Name: NameFull: Fusco N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1179-2000 Numbering: – Type: volume Value: 29 – Type: issue Value: 6 Titles: – TitleFull: Molecular diagnosis & therapy Type: main |
| ResultId | 1 |